世界の胆管がん市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Bile Duct Cancer Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0763 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、胆管がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（5-フルオロウラシル、ゲムシタビン、シスプラチン、その他）、用途別市場規模（病院・クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・胆管がんの市場動向 ・企業の競争状況、市場シェア ・胆管がんの種類別市場規模（5-フルオロウラシル、ゲムシタビン、シスプラチン、その他） ・胆管がんの用途別市場規模（病院・クリニック、その他） ・胆管がんの北米市場規模2016-2027（アメリカ、カナダ） ・胆管がんのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・胆管がんのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・胆管がんの中南米市場規模2016-2027（メキシコ、ブラジル） ・胆管がんの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、F. Hoffmann-La Roche、Bristol-Myers Squibb、Teva Pharmaceutical、Eli Lilly and Company、Sanofi、Fresenius Kabi、Mylan） ・結論

Bile duct cancer or cholangiocarcinoma is a form of cancer in which epithelial cells are mutated, i.e., they show epithelial differentiation in the bile duct. It is a type of rare neoplasm.

Market Analysis and Insights: Global Bile Duct Cancer Market
The global Bile Duct Cancer market size is projected to reach US$ 244.4 million by 2026, from US$ 151.8 million in 2019, at a CAGR of 7.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bile Duct Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bile Duct Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bile Duct Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bile Duct Cancer market.

Global Bile Duct Cancer Scope and Market Size
Bile Duct Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bile Duct Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
5-fluorouracil
Gemcitabine
Cisplatin
Other

Segment by Application
Hospitals & Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
F. Hoffmann-La Roche
Bristol-Myers Squibb
Teva Pharmaceutical
Eli Lilly and Company
Sanofi
Fresenius Kabi
Mylan

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bile Duct Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 5-fluorouracil
1.2.3 Gemcitabine
1.2.4 Cisplatin
1.2.5 Other
1.3 Market by Application
1.3.1 Global Bile Duct Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals & Clinics
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bile Duct Cancer Market Perspective (2016-2027)
2.2 Bile Duct Cancer Growth Trends by Regions
2.2.1 Bile Duct Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bile Duct Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Bile Duct Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Bile Duct Cancer Industry Dynamic
2.3.1 Bile Duct Cancer Market Trends
2.3.2 Bile Duct Cancer Market Drivers
2.3.3 Bile Duct Cancer Market Challenges
2.3.4 Bile Duct Cancer Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bile Duct Cancer Players by Revenue
3.1.1 Global Top Bile Duct Cancer Players by Revenue (2016-2021)
3.1.2 Global Bile Duct Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Bile Duct Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bile Duct Cancer Revenue
3.4 Global Bile Duct Cancer Market Concentration Ratio
3.4.1 Global Bile Duct Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bile Duct Cancer Revenue in 2020
3.5 Bile Duct Cancer Key Players Head office and Area Served
3.6 Key Players Bile Duct Cancer Product Solution and Service
3.7 Date of Enter into Bile Duct Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bile Duct Cancer Breakdown Data by Type
4.1 Global Bile Duct Cancer Historic Market Size by Type (2016-2021)
4.2 Global Bile Duct Cancer Forecasted Market Size by Type (2022-2027)

5 Bile Duct Cancer Breakdown Data by Application
5.1 Global Bile Duct Cancer Historic Market Size by Application (2016-2021)
5.2 Global Bile Duct Cancer Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bile Duct Cancer Market Size (2016-2027)
6.2 North America Bile Duct Cancer Market Size by Type
6.2.1 North America Bile Duct Cancer Market Size by Type (2016-2021)
6.2.2 North America Bile Duct Cancer Market Size by Type (2022-2027)
6.2.3 North America Bile Duct Cancer Market Size by Type (2016-2027)
6.3 North America Bile Duct Cancer Market Size by Application
6.3.1 North America Bile Duct Cancer Market Size by Application (2016-2021)
6.3.2 North America Bile Duct Cancer Market Size by Application (2022-2027)
6.3.3 North America Bile Duct Cancer Market Size by Application (2016-2027)
6.4 North America Bile Duct Cancer Market Size by Country
6.4.1 North America Bile Duct Cancer Market Size by Country (2016-2021)
6.4.2 North America Bile Duct Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Bile Duct Cancer Market Size (2016-2027)
7.2 Europe Bile Duct Cancer Market Size by Type
7.2.1 Europe Bile Duct Cancer Market Size by Type (2016-2021)
7.2.2 Europe Bile Duct Cancer Market Size by Type (2022-2027)
7.2.3 Europe Bile Duct Cancer Market Size by Type (2016-2027)
7.3 Europe Bile Duct Cancer Market Size by Application
7.3.1 Europe Bile Duct Cancer Market Size by Application (2016-2021)
7.3.2 Europe Bile Duct Cancer Market Size by Application (2022-2027)
7.3.3 Europe Bile Duct Cancer Market Size by Application (2016-2027)
7.4 Europe Bile Duct Cancer Market Size by Country
7.4.1 Europe Bile Duct Cancer Market Size by Country (2016-2021)
7.4.2 Europe Bile Duct Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bile Duct Cancer Market Size (2016-2027)
8.2 Asia-Pacific Bile Duct Cancer Market Size by Type
8.2.1 Asia-Pacific Bile Duct Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bile Duct Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bile Duct Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Bile Duct Cancer Market Size by Application
8.3.1 Asia-Pacific Bile Duct Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bile Duct Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bile Duct Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Bile Duct Cancer Market Size by Region
8.4.1 Asia-Pacific Bile Duct Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bile Duct Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bile Duct Cancer Market Size (2016-2027)
9.2 Latin America Bile Duct Cancer Market Size by Type
9.2.1 Latin America Bile Duct Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Bile Duct Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Bile Duct Cancer Market Size by Type (2016-2027)
9.3 Latin America Bile Duct Cancer Market Size by Application
9.3.1 Latin America Bile Duct Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Bile Duct Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Bile Duct Cancer Market Size by Application (2016-2027)
9.4 Latin America Bile Duct Cancer Market Size by Country
9.4.1 Latin America Bile Duct Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Bile Duct Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bile Duct Cancer Market Size (2016-2027)
10.2 Middle East & Africa Bile Duct Cancer Market Size by Type
10.2.1 Middle East & Africa Bile Duct Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bile Duct Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bile Duct Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Bile Duct Cancer Market Size by Application
10.3.1 Middle East & Africa Bile Duct Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bile Duct Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bile Duct Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Bile Duct Cancer Market Size by Country
10.4.1 Middle East & Africa Bile Duct Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bile Duct Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Bile Duct Cancer Introduction
11.1.4 Pfizer Revenue in Bile Duct Cancer Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Bile Duct Cancer Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Bile Duct Cancer Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Bile Duct Cancer Introduction
11.3.4 Bristol-Myers Squibb Revenue in Bile Duct Cancer Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Details
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Bile Duct Cancer Introduction
11.4.4 Teva Pharmaceutical Revenue in Bile Duct Cancer Business (2016-2021)
11.4.5 Teva Pharmaceutical Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Bile Duct Cancer Introduction
11.5.4 Eli Lilly and Company Revenue in Bile Duct Cancer Business (2016-2021)
11.5.5 Eli Lilly and Company Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Bile Duct Cancer Introduction
11.6.4 Sanofi Revenue in Bile Duct Cancer Business (2016-2021)
11.6.5 Sanofi Recent Development
11.7 Fresenius Kabi
11.7.1 Fresenius Kabi Company Details
11.7.2 Fresenius Kabi Business Overview
11.7.3 Fresenius Kabi Bile Duct Cancer Introduction
11.7.4 Fresenius Kabi Revenue in Bile Duct Cancer Business (2016-2021)
11.7.5 Fresenius Kabi Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan Bile Duct Cancer Introduction
11.8.4 Mylan Revenue in Bile Duct Cancer Business (2016-2021)
11.8.5 Mylan Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bile Duct Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 5-fluorouracil
Table 3. Key Players of Gemcitabine
Table 4. Key Players of Cisplatin
Table 5. Key Players of Other
Table 6. Global Bile Duct Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bile Duct Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Bile Duct Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Bile Duct Cancer Market Share by Regions (2016-2021)
Table 10. Global Bile Duct Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Bile Duct Cancer Market Share by Regions (2022-2027)
Table 12. Bile Duct Cancer Market Trends
Table 13. Bile Duct Cancer Market Drivers
Table 14. Bile Duct Cancer Market Challenges
Table 15. Bile Duct Cancer Market Restraints
Table 16. Global Bile Duct Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Bile Duct Cancer Market Share by Players (2016-2021)
Table 18. Global Top Bile Duct Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bile Duct Cancer as of 2020)
Table 19. Ranking of Global Top Bile Duct Cancer Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Bile Duct Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Bile Duct Cancer Product Solution and Service
Table 23. Date of Enter into Bile Duct Cancer Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bile Duct Cancer Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Bile Duct Cancer Revenue Market Share by Type (2016-2021)
Table 27. Global Bile Duct Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Bile Duct Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Bile Duct Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Bile Duct Cancer Revenue Market Share by Application (2016-2021)
Table 31. Global Bile Duct Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Bile Duct Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Bile Duct Cancer Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Bile Duct Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Bile Duct Cancer Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Bile Duct Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Bile Duct Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Bile Duct Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Bile Duct Cancer Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Bile Duct Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Bile Duct Cancer Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Bile Duct Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Bile Duct Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Bile Duct Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bile Duct Cancer Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bile Duct Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bile Duct Cancer Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Bile Duct Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Bile Duct Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Bile Duct Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Bile Duct Cancer Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Bile Duct Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Bile Duct Cancer Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Bile Duct Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Bile Duct Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Bile Duct Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bile Duct Cancer Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bile Duct Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bile Duct Cancer Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Bile Duct Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Bile Duct Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Bile Duct Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Bile Duct Cancer Product
Table 66. Pfizer Revenue in Bile Duct Cancer Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. F. Hoffmann-La Roche Company Details
Table 69. F. Hoffmann-La Roche Business Overview
Table 70. F. Hoffmann-La Roche Bile Duct Cancer Product
Table 71. F. Hoffmann-La Roche Revenue in Bile Duct Cancer Business (2016-2021) & (US$ Million)
Table 72. F. Hoffmann-La Roche Recent Development
Table 73. Bristol-Myers Squibb Company Details
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Bile Duct Cancer Product
Table 76. Bristol-Myers Squibb Revenue in Bile Duct Cancer Business (2016-2021) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Development
Table 78. Teva Pharmaceutical Company Details
Table 79. Teva Pharmaceutical Business Overview
Table 80. Teva Pharmaceutical Bile Duct Cancer Product
Table 81. Teva Pharmaceutical Revenue in Bile Duct Cancer Business (2016-2021) & (US$ Million)
Table 82. Teva Pharmaceutical Recent Development
Table 83. Eli Lilly and Company Company Details
Table 84. Eli Lilly and Company Business Overview
Table 85. Eli Lilly and Company Bile Duct Cancer Product
Table 86. Eli Lilly and Company Revenue in Bile Duct Cancer Business (2016-2021) & (US$ Million)
Table 87. Eli Lilly and Company Recent Development
Table 88. Sanofi Company Details
Table 89. Sanofi Business Overview
Table 90. Sanofi Bile Duct Cancer Product
Table 91. Sanofi Revenue in Bile Duct Cancer Business (2016-2021) & (US$ Million)
Table 92. Sanofi Recent Development
Table 93. Fresenius Kabi Company Details
Table 94. Fresenius Kabi Business Overview
Table 95. Fresenius Kabi Bile Duct Cancer Product
Table 96. Fresenius Kabi Revenue in Bile Duct Cancer Business (2016-2021) & (US$ Million)
Table 97. Fresenius Kabi Recent Development
Table 98. Mylan Company Details
Table 99. Mylan Business Overview
Table 100. Mylan Revenue in Bile Duct Cancer Business (2016-2021) & (US$ Million)
Table 101. Mylan Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bile Duct Cancer Market Share by Type: 2020 VS 2027
Figure 2. 5-fluorouracil Features
Figure 3. Gemcitabine Features
Figure 4. Cisplatin Features
Figure 5. Other Features
Figure 6. Global Bile Duct Cancer Market Share by Application: 2020 VS 2027
Figure 7. Hospitals & Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Bile Duct Cancer Report Years Considered
Figure 10. Global Bile Duct Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Bile Duct Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Bile Duct Cancer Market Share by Regions: 2020 VS 2027
Figure 13. Global Bile Duct Cancer Market Share by Regions (2022-2027)
Figure 14. Global Bile Duct Cancer Market Share by Players in 2020
Figure 15. Global Top Bile Duct Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bile Duct Cancer as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Bile Duct Cancer Revenue in 2020
Figure 17. Global Bile Duct Cancer Revenue Market Share by Type (2016-2021)
Figure 18. Global Bile Duct Cancer Revenue Market Share by Type (2022-2027)
Figure 19. North America Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Bile Duct Cancer Market Share by Type (2016-2027)
Figure 21. North America Bile Duct Cancer Market Share by Application (2016-2027)
Figure 22. North America Bile Duct Cancer Market Share by Country (2016-2027)
Figure 23. United States Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Bile Duct Cancer Market Share by Type (2016-2027)
Figure 27. Europe Bile Duct Cancer Market Share by Application (2016-2027)
Figure 28. Europe Bile Duct Cancer Market Share by Country (2016-2027)
Figure 29. Germany Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Bile Duct Cancer Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Bile Duct Cancer Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Bile Duct Cancer Market Share by Region (2016-2027)
Figure 39. China Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Bile Duct Cancer Market Share by Type (2016-2027)
Figure 47. Latin America Bile Duct Cancer Market Share by Application (2016-2027)
Figure 48. Latin America Bile Duct Cancer Market Share by Country (2016-2027)
Figure 49. Mexico Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Bile Duct Cancer Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Bile Duct Cancer Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Bile Duct Cancer Market Share by Country (2016-2027)
Figure 55. Turkey Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Bile Duct Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Bile Duct Cancer Business (2016-2021)
Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Bile Duct Cancer Business (2016-2021)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Bile Duct Cancer Business (2016-2021)
Figure 61. Teva Pharmaceutical Revenue Growth Rate in Bile Duct Cancer Business (2016-2021)
Figure 62. Eli Lilly and Company Revenue Growth Rate in Bile Duct Cancer Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Bile Duct Cancer Business (2016-2021)
Figure 64. Fresenius Kabi Revenue Growth Rate in Bile Duct Cancer Business (2016-2021)
Figure 65. Mylan Revenue Growth Rate in Bile Duct Cancer Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---